Utility of a Reverse Phase Protein Array to Evaluate Multiple Biomarkers in Diffuse Large B‐Cell Lymphoma-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Utility of a Reverse Phase Protein Array to Evaluate Multiple Biomarkers in Diffuse Large B‐Cell Lymphoma

Published:2019-11-27 Issue:1 Volume:14 Page:1900091
ISSN:1862-8346
Container-title:PROTEOMICS – Clinical Applications
language:en
Short-container-title:Prot. Clin. Appl.

Author:

Suzuki Masaki¹,Muroi Atsushi²,Nojima Masanori³,Numata Ayumi⁴,Takasaki Hirotaka⁴,Sakai Rika⁴,Yokose Tomoyuki¹,Miyagi Yohei⁵,Koshikawa Naohiko²^ORCID

Affiliation:

1. Department of PathologyKanagawa Cancer Center Yokohama 241‐8515 Japan

2. Division of Cancer Cell ResearchKanagawa Cancer Center Research Institute Yokohama 241‐8515 Japan

3. Center for Translational ResearchThe Institute of Medical Science HospitalUniversity of Tokyo Tokyo 108‐8639 Japan

4. Department of Hematology/Medical OncologyKanagawa Cancer Center Yokohama 241‐8515 Japan

5. Department of Molecular Pathology and GeneticsKanagawa Cancer Center Research Institute Yokohama 241‐8515 Japan

Publisher

Wiley

Subject

Clinical Biochemistry

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/prca.201900091

Reference27 articles.

1. A Clinical Evaluation of the International Lymphoma Study Group Classification of Non-Hodgkin's Lymphoma

2. Confirmation of the molecular classification of diffuse large B-cell lymphoma by immunohistochemistry using a tissue microarray

3. Evaluation of immunophenotype in diffuse large B-cell lymphoma and its impact on prognosis

4. Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling

5. De Novo CD5+ Diffuse Large B-Cell Lymphomas Express VH Genes With Somatic Mutation

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A reverse phase protein array based phospho-antibody characterization approach and its applicability for clinical derived tissue specimens;Scientific Reports;2022-12-26

2. Research progress in protein microarrays: Focussing on cancer research;PROTEOMICS – Clinical Applications;2022-10-31

3. Methods of Protein Detection in Cancer for Diagnosis, Prognosis and Therapy;Protein Detection;2022-06-23

4. Clinicopathologic and protein markers distinguishing the “polymerase epsilon exonuclease” from the “copy number low” subtype of endometrial cancer;Journal of Gynecologic Oncology;2022

5. Ruxolitinib as a Novel Therapeutic Option for Poor Prognosis T-LBL Pediatric Patients;Cancers;2021-07-24

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3